Back to Search

Certolizumab pegol – Uses, Dosage, and Brands in UAE

Brand Name: CIMZIA
Strength: 200 mg/ml | Form: Solution For Injection
Price in UAE: AED 4395.50
Available in UAE pharmacies

About Certolizumab pegol

Class: | Biologic, Tumor Necrosis Factor (TNF) Inhibitor Use: | Treatment of moderate to severe rheumatoid arthritis, Crohn's disease, ankylosing spondylitis, psoriatic arthritis, and hidradenitis suppurativa. Adult dose: | Initial dose of 400 mg (administered as two 200 mg injections) at week 0, followed by 200 mg every other week starting at week 2. Pediatric dose: | For pediatric Crohn's disease, initial dose of 400 mg (administered as two 200 mg injections) at week 0, followed by 200 m

Drug Class

Biologic, Tumor Necrosis Factor (TNF) Inhibitor

Uses & Indications

Treatment of moderate to severe rheumatoid arthritis, Crohn's disease, ankylosing spondylitis, psoriatic arthritis, and hidradenitis suppurativa.

Storage Requirements

Store in the refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. Protect from light.

Manufacturer & Packaging

Manufacturer: UCB Pharma S.A., BELGIUM

Package Size

1ml Pre-filled Syringe x 2 + 2 Alcohol Wipes

Price & Supplier

Price in UAE: AED 4395.50

Dosage Information

Adult Dose

Initial dose of 400 mg (administered as two 200 mg injections) at week 0, followed by 200 mg every other week starting at week 2.

Pediatric Dose

For pediatric Crohn's disease, initial dose of 400 mg (administered as two 200 mg injections) at week 0, followed by 200 mg every other week starting at week 2 for patients aged 6 years and older.

Side Effects

Common side effects include injection site reactions, headache, nausea, fatigue, and increased risk of infections.

Contraindications & Precautions

Contraindicated in patients with a history of serious hypersensitivity reactions to Certolizumab pegol or any of its components, active infections (including tuberculosis), and in patients with moderate to severe heart failure.

Important Warnings

Increased risk of serious infections, including tuberculosis; malignancies; and potential for liver injury. Patients should be screened for tuberculosis prior to initiation and monitored during treatment.

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. The information presented here is specific to medicines available in UAE pharmacies and is regularly updated to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.

View All Biologic, Tumor Necrosis Factor (TNF) Inhibitor Medicines Browse All Categories